Effects of acepromazine and buprenorphine on measured indices of the signal-averaged electrocardiogram in healthy dogs

American Journal of Veterinary Research

Volumn 57, Issue 10, 1996, Pages 1511-1514

  Kushner, Lynne I ^a,c   Calvert, Clay A ^a   Boyle, Carolyn R ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b MISSISSIPPI STATE UNIVERSITY   (United States)

^c MISSISSIPPI STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEPROMAZINE; BUPRENORPHINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; ELECTROCARDIOGRAM; FEMALE; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; SEDATION;

ACEPROMAZINE; ANIMALS; BUPRENORPHINE; DOGS; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; MALE; REFERENCE VALUES; SOFTWARE; STATISTICS, NONPARAMETRIC; TIME FACTORS;

ANIMALIA; CANIS FAMILIARIS;

EID: 0029856927     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Calvert CA. Dilated congestive cardiomyopathy in Doberman Pinschers. Compend Contin Educ Prac Vet 1986;8:417-430.
2. Simson MB. Use of signals in the terminal QRS complex to identify patients with ventricular tachycardia after myocardial infarction. Circulation 1981;64:235-242.
3. Denes P, Santarelli P, Hauser RG, et al. Quantitative analysis of the high-frequency components of the terminal portion of the body surface QRS in normal subjects and in patients with ventricular tachycardia. Circulation 1983;647:1129-1138.
4. Landers P, Berbari EJ, Rajagopalan CV, et al. Critical analysis of the signal-averaged electrocardiogram: improved identification of late potentials. Circulation 1993;87:105-117.
5. Poll DS, Marchlinski FE, Falcone RA, et al. Abnormal signal-averaged electrocardiograms in patients with nonischemic congestive cardiomyopathy: relationship to sustained ventricular tachyarrhythmias. Circulation 1985;72:1308-1313.
6. Berbari EJ, Lazzara R. An introduction to high-resolution ECG recordings of cardiac late potentials. Arch Intern Med 1988;48: 1859-1863.
7. Breithardt G, Borggrefe M. Pathophysiological mechanisms and clinical significance of ventricular late potentials. Eur Heart J 1986;7:364-385.
8. Spear JF, Richards DA, Blake GJ, et al. The effects of premature stimulation of the His bundle on epicardial activation and body surface late potentials in dogs susceptible to sustained ventricular tachyarrhythmias. Circulation 1985;72:214-224.
9. Berbari EJ, Scherlag BJ, Hope RR, et al. Recording from the body surface of arrhythmogenic ventricular activity during the ST segment. Am J Cardiol 1978;41:697-702.
10. Simson MB, Euler D, Michelson EL, et al. Detection of delayed ventricular activation on the body surface in dogs. Am J Physiol 1981;241:H363-H368.
11. Hombach V, Braun V, Hopp HW, et al. The applicability of the signal averaging technique in clinical cardiology. Clin Cardiol 1982;5:107-124.
12. Simson MB. Signal-averaged electrocardiography. In: Zipes D, Jalife J, eds. Cardiac electrophysiology from cell to bedside. Philadelphia: WB Saunders, 1990:807-817.
13. Steinberg JS, Bigger JT. Importance of the endpoint of noise reduction in analysis of the signal-averaged electrocardiogram. Am J Cardiol 1989;63:556-560.
14. Breithardt G, Cain ME, El-Sherif N, et al. Standards for analysis of ventricular late potentials using high-resolution or signal-averaged electrocardiography: a statement by a task force committee of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology. Am Coll Cardiol 1991;17:999-1006.
15. Gang ES, Peter T, Rosenthal ME, et al. Detection of late potentials on the surface electrocardiogram in unexplained syncope. Am J Cardiol 1986;58:1014-1020.
16. Calvert CA. High-resolution electrocardiography (signal-averaged electrocardiography) in normal Doberman Pinschers and Doberman Pinschers with occult cardiomyopathy, in Proceedings. 9th Am Coll Vet Intern Med Forum 1991;693-695.
17. Miller MS, Calvert CA. Special methods for analyzing arrhythmias. In: Tilley LP, ed. Essentials of canine and feline electrocardiography. Interpretation and treatments. 3rd ed. Philadelphia: Lea & Febiger, 1992;313-319.
18. Craelius W, Restivo M, El-Sherif N. Techniques for processing of cardiac signals: fiducial formulae for fidelity. In: El-Sherif N, Turrito G, eds. High-resolution electrocardiography. Mount Kisco, NY: Futura Publishing Co, 1992;21-49.
19. Booth NH. Psychotropic agents. In: Booth NH, McDonald LE, eds. Veterinary pharmacology and therapeutics. Ames, Iowa: Iowa State University Press, 1982;321-345.
20. Muir WW III, Werner LL, Hamlin RL. Effects of xylazine and acetylpromazine upon induced ventricular fibrillation in dogs anesthetized with thiamylal and halothane. Am J Vet Res 1975;36: 1299-1303.
21. Arita M, Surawicz B. Electrophysiologic effects of phenothiazines on canine cardiac fibers. J Pharmacol Exp Ther 1973;184: 619-630.
22. Balddessarini RJ. Drugs and the treatment of psychiatric disorders. In: Gilman AG, Rall TW, Nies AS, et al, eds. Goodman and Gilman's the pharmacological basis of therapeutics. New York: Peragon Press, 1990;383-401.
23. Adamantidis MM, Kerram P, Caron JF, et al. Droperidol exerts dual effects on repolarization and induces early after depolarizations and triggered activity in rabbit Purkinje fibers. J Pharmacol Exp Ther 1993;266:884-893.
24. Jaffe JH, Martin WR. Opioid analgesics and antagonists. In: Gilman AG, Rall TW, Nies AS, eds, et al. Goodman and Gilman's the pharmacological basis of therapeutics. New York: Peragon Press, 1990; 485-521.
25. Boachie-Ansah G, Sitsapesan R, Kane KA, et al. The antiarrhythmic and cardiac electrophysiological effects of buprenorphine. Br J Pharmacol 1989;97:801-808.